TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30782281

Group type: EXPERIMENTAL
Intervention: Alanyl-glutamine-enriched nutritional support
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (nutritional support without alanyl-glutamine)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 225
Study: 27549309

Group type: EXPERIMENTAL
Intervention: 1000 IU cholecalciferol/day
Number of subjects: 203

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 203
Study: 27803047

Group type: COMPARATOR
Intervention: diet
Number of subjects: 439

Group type: COMPARATOR
Intervention: exercise
Number of subjects: 439

Group type: COMPARATOR
Intervention: diet + exercise
Number of subjects: 439

Group type: COMPARATOR
Intervention: control
Number of subjects: 439
Study: 25136550

Group type: EXPERIMENTAL
Intervention: 12-week lifestyle intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Advice-only control group
Number of subjects: 60
Study: 22440491

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tirofiban 25 μg/kg bolus
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tirofiban bolus with post-bolus 2-h infusion
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tirofiban bolus with concomitant prasugrel
Number of subjects: 100
Study: 21053455

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids and beta2 agonists for eight weeks (Group A)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oral beta2 agonists only for eight weeks (Group B)
Number of subjects: 55
Study: 17692642

Group type: EXPERIMENTAL
Intervention: rFVIIa (40 microg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 20
Study: 15881482

Group type: EXPERIMENTAL
Intervention: Rilmenidine (1 mg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lisinopril (10 mg)
Number of subjects: 51
Study: 12056584

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 80
Study: 10421037

Group type: EXPERIMENTAL
Intervention: Pefloxacin (group P, 316 patients)
Number of subjects: 616

Group type: COMPARATOR
Intervention: Cefazolin-oxacillin combination (group C, 300 patients)
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Both groups (P and C)
Number of subjects: 616
Study: 7499684

Group type: EXPERIMENTAL
Intervention: 400 ppb NO2 for 6 hours
Number of subjects: 8

Group type: COMPARATOR
Intervention: Air for 6 hours
Number of subjects: 8
Study: 2205964

Group type: EXPERIMENTAL
Intervention: Naltrexone (25 mg on the first day, then 50 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study: 6444678

Group type: EXPERIMENTAL
Intervention: Topical program of tretinoin, benzoyl peroxide, and water avoidance
Number of subjects: 118

Group type: COMPARATOR
Intervention: Systemic tetracycline therapy with abradant cleansers
Number of subjects: 118

Group type: COMPARATOR
Intervention: Systemic tetracycline therapy with topically applied tretinoin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Topical program
Number of subjects: 118
Study: 31977842

Group type: EXPERIMENTAL
Intervention: Letrozole (5.0 mg/d on days 3-5 of menstrual cycle for 5 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Human Menopausal Gonadotropin (75 U/d intramuscular injection starting from day 3 of menstrual cycle for 5 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Human Menopausal Gonadotropin
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 96
Study: 31614331

Group type: EXPERIMENTAL
Intervention: Cluster-set configuration (20-s rest every 2 repetitions)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Traditional-set configuration (no interrepetition rest)
Number of subjects: 26
Study: 27683073

Group type: EXPERIMENTAL
Intervention: Monophasic bone substitute (MBS) - Bioresorb®
Number of subjects: 60

Group type: COMPARATOR
Intervention: Biphasic bone substitute (BBS) - Maxresorb®
Number of subjects: 60
Study: 25255846

Group type: EXPERIMENTAL
Intervention: Cued belief about the diagnostic saliency of the task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral directions
Number of subjects: 0
Study: 23111014

Group type: EXPERIMENTAL
Intervention: Negative pressure wound dressing treatment (Prevena, KCI, Wiesbaden, Germany) with -125 mm Hg for 6 to 7 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional sterile wound dressing
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Negative pressure wound dressing treatment
Number of subjects: 150
Study: 21307985

Group type: EXPERIMENTAL
Intervention: Diabetes self-management intervention (telehealth)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 47
Study: 19296295

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz, 90% motor threshold) applied to the left temporoparietal cortex for 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group receiving only antipsychotics
Number of subjects: 40
Study: 17095936

Group type: EXPERIMENTAL
Intervention: High-repetition, short-rest resistance training (three to five sets of 15-20 reps, 20 s rest)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-repetition, short-rest resistance training
Number of subjects: 16
Study: 15271706

Group type: EXPERIMENTAL
Intervention: Sevoflurane in 100% oxygen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane in 50% nitrous oxide/50% oxygen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Halothane in 50% nitrous oxide/50% oxygen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0

Group type: COMPARATOR
Intervention: All groups (Sevoflurane and Halothane)
Number of subjects: 0
Study: 10337723

Group type: EXPERIMENTAL
Intervention: Vitamins and antioxidants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibre supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary modifications
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8943580

Group type: EXPERIMENTAL
Intervention: Cocaine treatment trial
Number of subjects: 0
Study: 1742266

Group type: EXPERIMENTAL
Intervention: 10% solution of povidine-iodine for pre-operative skin preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No skin preparation (control group)
Number of subjects: 0
Study: 6128012

Group type: EXPERIMENTAL
Intervention: Org NC 45 (0.1 mg kg‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pancuronium (0.1 mg kg‐1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Org NC 45
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 50
Study: 30887190

Group type: EXPERIMENTAL
Intervention: CHTC + SUM
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CHTC + CT videos + SUM
Number of subjects: 70

Group type: COMPARATOR
Intervention: CHTC
Number of subjects: 70
Study: 28493510

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.45 mg.kg‐1 with neostigmine (50 μg.kg‐1 with glycopyrrolate 10 μg.kg‐1)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Rocuronium 0.90 mg.kg‐1 with sugammadex (4 mg.kg‐1)
Number of subjects: 44
Study: 24786514

Group type: EXPERIMENTAL
Intervention: Heavy Resistance Exercise (HRE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 0
Study: 22451244

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 5 mg oxycodone hydrochloride
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Oral solution of 5 mg oxycodone hydrochloride
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Capsule of 5 mg oxycodone hydrochloride
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Controlled-release tablet of 5 mg oxycodone hydrochloride
Number of subjects: 15
Study: 20965827

Group type: EXPERIMENTAL
Intervention: Pulsed magnetic field treatment (20-40 mT, 50 Hz, 20 min per time, 1 time per day for 14 days)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 65
Study: 18044282

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.8-microg/kg bolus, 0.4 microg kg(‐1) h)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80
Study: 16247147

Group type: EXPERIMENTAL
Intervention: MR angiography
Number of subjects: 157

Group type: COMPARATOR
Intervention: MDCT angiography
Number of subjects: 157
Study: 12233986

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 166

Group type: COMPARATOR
Intervention: Cocaine use
Number of subjects: 166
Study: 9872822

Group type: EXPERIMENTAL
Intervention: Inhaled formoterol (Foradil) 24 microgram, twice a day for 8 weeks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide 400 microgram, twice a day for 8 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Matched placebo inhaled twice a day for 8 weeks
Number of subjects: 64
Study: 7720758

Group type: EXPERIMENTAL
Intervention: Captopril 12.5-50 mg per day (divided in 2-3 doses) p.o. in addition to 'conventional' therapy with digoxin and diuretics
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional therapy only (control group)
Number of subjects: 19
Study: 1827043

Group type: EXPERIMENTAL
Intervention: Betaxolol, furosemide, and minoxidil combination
Number of subjects: 30
Study: 7075115

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Tobramycin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Comparison of predicted levels
Number of subjects: 82
Study: 30291547

Group type: EXPERIMENTAL
Intervention: Animation-assisted education program (4.29 minutes duration)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Comparison group (no animation-assisted education)
Number of subjects: 80
Study: 30765298

Group type: EXPERIMENTAL
Intervention: Meal bundling intervention (promoted through displays and point-of-purchase messaging for 4 weeks)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Electronic reminders (weekly messages based on behavioral psychology principles)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 300
Study: 29929537

Group type: EXPERIMENTAL
Intervention: Risperidone (up to 4 mg orally)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (inert)
Number of subjects: 50
Study: 27090728

Group type: EXPERIMENTAL
Intervention: Thoracoscopic splanchnicectomy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Analgesic pharmacotherapy
Number of subjects: 52
Study: 24108527

Group type: EXPERIMENTAL
Intervention: Galsulfase 1.0 mg/kg/week
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Galsulfase 2.0 mg/kg/week
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Galsulfase 1.0 mg/kg/week and 2.0 mg/kg/week
Number of subjects: 4
Study: 22042159

Group type: EXPERIMENTAL
Intervention: Interaction with a woman via computer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticipation of interaction with a woman
Number of subjects: 0

Group type: COMPARATOR
Intervention: No interaction or information about woman's attractiveness
Number of subjects: 0
Study: 19556526

Group type: EXPERIMENTAL
Intervention: Gait training with body weight support on a treadmill (n=52)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional treatment with overground gait training only (n=45)
Number of subjects: 97
Study: 17456677

Group type: EXPERIMENTAL
Intervention: Transforaminal (TF) epidural steroid injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Interlaminar (IL) epidural steroid injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Caudal (C) epidural steroid injection
Number of subjects: 90
Study: 17593956

Group type: EXPERIMENTAL
Intervention: Vitamin A
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Vitamin A and Zinc
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Multiple Micronutrients
Number of subjects: 373

Group type: COMPARATOR
Intervention: Zinc or Multiple Micronutrients
Number of subjects: 373

Group type: COMPARATOR
Intervention: Upper Respiratory Symptoms
Number of subjects: 373

Group type: COMPARATOR
Intervention: Incidence of Pneumonia
Number of subjects: 373
Study: 15237417

Group type: EXPERIMENTAL
Intervention: Providing heroin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heroin provision in the Netherlands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Critique on the heroin RCT
Number of subjects: 0
Study: 11077586

Group type: EXPERIMENTAL
Intervention: Laparoscopic placement behind the cardia (RKP)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Retrogastric placement (RGP)
Number of subjects: 101
Study: 8885803

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aqueous nasal spray (220 micrograms/day)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 1333781

Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg (C200)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Celiprolol 400 mg (C400)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Celiprolol 800 mg (C800)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Celiprolol (C200, C400, C800)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Celiprolol (C400, C800)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Atenolol (A50, A100, A200)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nadolol (N40)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 8
Study: 6724256

Group type: EXPERIMENTAL
Intervention: chenodeoxycholic acid (1 g/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ursodeoxycholic acid (1 g/day)
Number of subjects: 10
Study: 31070386

Group type: EXPERIMENTAL
Intervention: Alcohol brief motivational intervention (BMI) plus substance-free activity session (SFAS)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Alcohol brief motivational intervention (BMI) plus relaxation training (RT)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 393
Study: 30125731

Group type: EXPERIMENTAL
Intervention: Short stay unit (SSU) management of AHF (<24 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard hospitalization for AHF
Number of subjects: 0
Study: 27452372

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 24268822

Group type: COMPARATOR
Intervention: Conventional drilling
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 30
Study: 22121923

Group type: EXPERIMENTAL
Intervention: eGFR(cystatin C)
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: eGFR(creatinine)
Number of subjects: 857

Group type: COMPARATOR
Intervention: Combined cystatin C- and creatinine-based estimation of GFR
Number of subjects: 857
Study: 19723695

Group type: EXPERIMENTAL
Intervention: Valsartan add-on treatment
Number of subjects: 3031

Group type: COMPARATOR
Intervention: Non-ARB treatment
Number of subjects: 3031
Study: 17484536

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 58

Group type: COMPARATOR
Intervention: Bare metal stents
Number of subjects: 58
Study: 16080838

Group type: EXPERIMENTAL
Intervention: High-dose glucose-insulin-potassium (GIK) infusion for 24 hours
Number of subjects: 74

Group type: COMPARATOR
Intervention: Vehicle group (non-GIK)
Number of subjects: 74
Study: 11786288

Group type: EXPERIMENTAL
Intervention: Depressed women
Number of subjects: 148

Group type: COMPARATOR
Intervention: Nondepressed women
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: African-American women
Number of subjects: 148
Study: 9667263

Group type: EXPERIMENTAL
Intervention: More intensive preoperative chemotherapy regimen (two courses of cisplatin and doxorubicin in addition to high‐dose methotrexate and bleomycin, cyclophosphamide, and dactinomycin)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control arm (therapy based on the T10 protocol)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: More intensive preoperative chemotherapy regimen
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 73
Study: 8138256

Group type: EXPERIMENTAL
Intervention: Interferon-alpha treatment for 4 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Nontreated control group
Number of subjects: 33
Study: 2686525

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 632
Study: 31280705

Group type: EXPERIMENTAL
Intervention: Ficolled bone marrow
Number of subjects: 19

Group type: COMPARATOR
Intervention: BM buffy coat
Number of subjects: 19
Study: 28270726

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy (30 minutes daily for 2 weeks)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (chemotherapy only)
Number of subjects: 56
Study: 25681965

Group type: EXPERIMENTAL
Intervention: 10 days of antibiotic therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: 14 days of antibiotic therapy
Number of subjects: 70
Study: 24570387

Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal tDCS, 2 mA for 7 min to the primary motor cortex)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo group (tDCS electrode montage with only 30 s of active tDCS stimulation)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Natural history group (no tDCS montage, same pain stimulation)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 75
Study: 22884794

Group type: EXPERIMENTAL
Intervention: GnRH agonist
Number of subjects: 32

Group type: COMPARATOR
Intervention: GnRH antagonist
Number of subjects: 32
Study: 20137437

Group type: EXPERIMENTAL
Intervention: Intradiscal injection of diprospan (compound betamethasone) 3 ml (B group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Interventional injection of diprospan (compound betamethasone) 1 ml + songmeile (cervus & cucumis polypeptide injection) 2 ml (C group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intradiscal injection of normal saline 3 ml (A group, control)
Number of subjects: 60
Study: 18075283

Group type: EXPERIMENTAL
Intervention: Acute insulin infusion (euglycemic hyperinsulinemic clamp)
Number of subjects: 16
Study: 15007248

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy in locally advanced gastric cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant radiochemotherapy in gastric cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New substances like taxanes or irinotecan
Number of subjects: 0
Study: 12614251

Group type: EXPERIMENTAL
Intervention: Tolterodine 2 mg twice daily plus simplified bladder training (BT)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Tolterodine alone
Number of subjects: 505
Study: 10325795

Group type: EXPERIMENTAL
Intervention: Sucrose administered into the mouth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sucrose administered intragastrically
Number of subjects: 0
Study: 7569002

Group type: EXPERIMENTAL
Intervention: Split course therapy
Number of subjects: 273

Group type: COMPARATOR
Intervention: Conventional daily radiation therapy
Number of subjects: 273
Study: 2022800

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg daily)
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15000
Study: 7015797

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg once daily, increased to 200 mg if needed)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once daily, increased to 200 mg if needed)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Both metoprolol and atenolol
Number of subjects: 55
Study: 30587066

Group type: EXPERIMENTAL
Intervention: Supervised treadmill exercise
Number of subjects: 156

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 156
Study: 28335446

Group type: EXPERIMENTAL
Intervention: Educational poster and accompanying evaluation and triage guide
Number of subjects: 1171
Study: 26716547

Group type: EXPERIMENTAL
Intervention: Oral propranolol combined with topical timolol maleate (Experimental group A)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Oral propranolol alone (Control group B)
Number of subjects: 31
Study: 24868014

Group type: EXPERIMENTAL
Intervention: 15% H(2)O(2) bleaching agent with TiO_N photocatalyzed with LED/laser light (HP15)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 35% H(2)O(2) (HP35)
Number of subjects: 40
Study: 21738095

Group type: EXPERIMENTAL
Intervention: Physician education alone (GI)
Number of subjects: 1322

Group type: EXPERIMENTAL
Intervention: Physician education in combination with motivational counseling (MC)
Number of subjects: 1322

Group type: COMPARATOR
Intervention: Postal dissemination of the guideline (Control group, C)
Number of subjects: 1322
Study: 19711034

Group type: EXPERIMENTAL
Intervention: General endotracheal anesthesia for transfemoral valve implantation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transfemoral valve implantation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transapical valve implantation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Post-valve implantation
Number of subjects: 100
Study: 17241304

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (400 mg b.i.d.), tetracycline (500 mg q.i.d.), and metronidazole (250 mg q.i.d.)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg b.i.d.), amoxicillin (1 g b.i.d.), and omeprazole (20 mg b.i.d.)
Number of subjects: 100
Study: 15250777

Group type: EXPERIMENTAL
Intervention: Sum-difference Theory of remembering and knowing (STREAK)
Number of subjects: 373

Group type: COMPARATOR
Intervention: One-dimensional model
Number of subjects: 373
Study: 11852167

Group type: EXPERIMENTAL
Intervention: Planned cesarean section
Number of subjects: 2088

Group type: COMPARATOR
Intervention: Planned vaginal birth
Number of subjects: 2088
Study: 9226356

Group type: EXPERIMENTAL
Intervention: High-fat yogurt condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-fat yogurt condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carbohydrate content (varied in yogurt)
Number of subjects: 40
Study: 8497553

Group type: EXPERIMENTAL
Intervention: High intensity exercise (70% VO2max)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (50% VO2max)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Light exercise control
Number of subjects: 72